Please login to the form below

Not currently logged in
Email:
Password:

CureVac’s CEO appointed to EC High Level Group

Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes

Dr Ingmar Hoerr, chief executive officer of clinical-stage mRNA technology specialist CureVac, has been appointed to the European Commission's High Level Group for research and innovation programmes.

Dr Hoerr joins a panel of 15 group members who will advise the EC on how to strengthen support for breakthrough, market-creating innovation in the Horizon 2020 project as well as future programmes.

He brings 17 years of experience as the founder and chief executive of CureVac, which specialises in the research and development of treatments that instruct the human body to produce its own proteins to combat a range of diseases.

Dr Hoerr said: “It is a tremendous honor to be selected by the European Commission as member of the High Level Group focused on advancing innovation throughout the European Union.

“As one of the pioneering companies in mRNA therapeutics, CureVac is at the forefront of medical innovation, and I am delighted that our experience and leadership will benefit the next generation of European entrepreneurs who are seeking to improve the world through science.”

Dr Hoerr is joined in the High Level Group by entrepreneur and tech investor Nicklas Bergman, Steam Capital founder Martin Bruncko, Web Summit founder Paddy Cosgrave and Ludgate Hub chief executive Gráinne Dwyer.

Also appointed are Amadeus Capital Partners co-founder Hermann Maria Hauser, Plant-e founder Marjolein Helder, TransferWise chief executive Taavet Hinrikus and start-up expert Bindi Karia.

Governing board member of the European Institute for Innovation and Technology Jana Kolar joins, as does ebankIT chief executive Pathena Carlos Oliveira.

The remaining appointees are World Economic Forum board of trustees member Jim Hagemann Snabe, Experior Venture Fund founder Kinga Stanisławska, special envoy for StartupDelta Constantijn Van Oranje-Nassau, and StationF chief executive Roxanne Varza.

2nd February 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics